NOVEL GENOTYPE IN TWO SIBLINGS WITH 5-α- REDUCTASE 2 DEFICIENCY: DIFFERENT CLINICAL COURSE DUE TO THE TIME OF DIAGNOSIS
Kocova M1,*, Plaseska-Karanfilska D2, Noveski P2, Kuzmanovska M2
*Corresponding Author: Professor Dr. Mirjana Kocova, University Pediatric Clinic, Department of Endocrinology & Genetics, M. Tereza 17, Skopje 1000, Republic of North Macedonia. Tel: +389-70- 242-694. Fax: +389-317-6167. E-mail: mirjanakocova@yahoo.com
page: 69

REFERENCES

1. Mendonca BB, Domenice S, Arnhold IJ, Costa EM. 46,XY Disorders of sex development (DSD). Clin Endo-crinol (Oxf). 2009; 70(2): 173-187. 2. Hochberg Z, Chayen R, Reiss N, Falik Z, Makler A, Munichor M, et al. Clinical, biochemical, and genetic findings in a large pedigree of male and female patients with 5 alpha-reductase 2 deficiency. J Clin Endocrinol Metab. 1996; 81(8): 2821-2827. 3. Maimoun L, Philibert P, Cammas B, Audran F, Bouchard P, Fenichel P, et al. Phenotypical, biological, and molecular heterogeneity of 5 α-reductase deficiency: An extensive international experience of 55 patients. J Clin Endocrinol Metab. 2011; 96(2): 296-307. 4. Andersson S, Berman DM, Jenkins EP, Russell DW. Deletion of steroid 5 α-reductase 2 gene in male pseudo-hermaphroditism. Nature. 1991; 354(6349): 159-161. 5. Vilchis F, Ramos L, Mendez JP, Benavides S, Canto P, Chavez B. Molecular analysis of the SRD5A2 in 46,XY subjects with incomplete virilization: The P212R substitution of the steroid 5 α-reductase 2 may constitute an ancestral founder mutation in Mexican patients. J Androl. 2010; 31(4): 358-364. 6. Imperato-McGinley J, Zhu YS. Androgens and male physiology the syndrome of 5 α-reductase-2 deficiency. Mol Cell Endocrinol. 2002; 198(1-2): 51-59. 7. Sasaki G, Ogata T, Ishii T, Kosaki K, Sato S, Homma K, et al. Micropenis and the 5 α-reductase-2 (SRD5A2) gene: Mutation and V89L polymorphism analysis in 81 Japanese patients. J Clin Endocrinol Metab. 2003; 88(7): 3431-3436. 8. Thigpen AE, Davis DL, Gautier T, Imperato-McGinley J, Russell DW. Brief report: The molecular basis of steroid 5 α-reductase deficiency in a large Dominican kindred. N Engl J Med. 1992; 327(17): 1216- 1219. 9. Alswailem MM, Alzahrani OS, Alghofaili L, Qasem E, Almohanaa M, Alsagheir A, et al. Molecular genetics and phenotype/genotype correlation of 5-α reductase deficiency in a highly consanguineous population. Endocrine. 2019; 63(2): 361-368. 10. M Selveindran N, Syed Zakaria SZ, Jalaludin MY, Rasat R. Quality of life in children with disorders of sex development. Horm Res Paediatr. 2017; 88(5): 324-330. 11. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier- Foster J, et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5): 405-424. 12. Nicoletti A, Baldazzi L, Balsamo A, Barp L, Pirazzoli P, Gennari M, et al. SRD5A2 gene analysis in an Italian population of under-masculinized 46,XY subjects. Clin Endocrinol (Oxf). 2005; 63(4): 375-380. 13. Avendano A, Paradisi I, Cammarata-Scalisi F, Callea M. 5-α-Reductase type 2 deficiency: Is there a genotype- phenotype correlation? A review. Hormones (Athens). 2018; 17(2): 197-204. 14. Andonova S, Robeva R, Vazharova R, Ledig S, Grozdanova L, Stefanova E, et al. New territory for an old disease: 5-α-reductase type 2 deficiency in Bulgaria. Sex Dev. 2017; 11(1): 21-28. 15. Perry RJ, Novikova E, Wallace AM, Donaldson MD. Pitfalls in the diagnosis of 5 α-reductase type 2 deficiency during early infancy. Horm Res Paediatr. 2011; 75(5): 380-382. 16. Chan AO, But BW, Lee CY, Lam YY, Ng KL, Tung JY, et al. Diagnosis of 5 α-reductase 2 deficiency: Is measurement of dihydrotestosterone essential? Clin Chem. 2013; 59(5): 798-806. 17. Hackel C, Oliveira LE, Ferraz LF, Tonini MM, Silva DN, Toralles MB, et al. New mutations, hotspots, and founder effects in Brazilian patients with steroid 5 α-reductase deficiency type 2. J Mol Med (Berl). 2005; 83(7): 569-576. 18. Karczewski K, Francioli L. The genome Aggregation Database (gnomAD). MacArthur Lab. 2017. (https:// macarthurlab.org/2017/02/27/the-genomeaggregation- database-gnomad/.) 19. Silveri RI, Russell DW. 5 α-Reductase type 2 mutations are present in some boys with isolated hypospadias. J Urol. 1999; 162(3): 1142-1145. 20. Rahimi M, Ghanbari M, Fazeli Z, Rouzrokh M, Omrani S, Mirfakhraie R, et al. Association of SRD5A2 gene mutations with risk of hypospadias in the Iranian population. J Endocrinol Invest. 2017; 40(4): 391-396. 21. Samtani R, Bajpai M, Ghosh P, Saraswathy K. SRD5A2 gene mutations A population-based review. Pediatr Endocrinol Rev. 2010; 8(1): 34-40. 22. Fang C, Guo ZQ, Chen XY, Liu TZ, Zeng XT, Wang XH. Relationship between SRD5A2 rs9282858 polymorphism and the susceptibility of prostate cancer: A meta-analysis based on 20 publications. Medicine (Baltimore). 2017; 96(19): e6791. 23. Pearce CL, van den Berg DJ, Makridakis N, Reichardt JK, Ross RK, Pike MC, et al. No association between the SRD5A2 gene A49T missense variant and prostate cancer risk: Lessons learned. Hum Mol Genet. 2008; 17(16): 2456-2461. 24. Costa EM, Domenice S, Sircili MH, Inacio M, Mendonca BB. DSD due to 5 α-reductase 2 deficiency From diagnosis to long term outcome. Semin Reprod Med. 2012; 30(5): 427-431. 25. Byers HM, Mohnach LH, Fechner PY, Chen M, Thomas IH, Ramsdell LA, et al. Unexpected ethical dilemmas in sex assignment in 46,XY DSD due to 5-α reductase type 2 deficiency. Am J Med Genet C Semin Med Genet. 2017; 175(2): 260-267. 26. Houk CP, Lee PA. Consensus statement on terminology and management: Disorders of sex development. Sex Dev. 2008; 2(4-5): 172-180. 27. Wisniewski AB, Mazur T. 46,XY DSD with female or ambiguous external genitalia at birth due to androgen insensitivity syndrome, 5 α-reductase-2 deficiency, or 17 β-hydroxysteroid dehydrogenase deficiency: A review of quality of life outcomes. Int J Pediatr Endocrinol. 2009; 2009: 567430. 28. Fenichel P, Paris F, Philibert P, Hieronimus S, Gaspari L, Kurzenne JY, et al. Molecular diagnosis of 5 α-reductase deficiency in 4 elite young female athletes through hormonal screening for hyperandrogenism. J Clin Endocrinol Metab. 2013; 98(6): E1055-E1059.



Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006